Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enabling Radiation Hardness in Solid-State NAND Storage Utilizing a Laminated Ferroelectric Stack.

Nano letters·2026
Same author

ALD-Derived WO<sub>3-<i>x</i></sub> Leads to Nearly Wake-Up-Free Ferroelectric Hf<sub>0.5</sub>Zr<sub>0.5</sub>O<sub>2</sub> at Elevated Temperatures.

ACS applied electronic materials·2026
Same author

Human CSF proteogenomics links genetic variation to neurodegenerative disease proteins.

medRxiv : the preprint server for health sciences·2026
Same author

CSF turnover reshapes biomarker interpretation in neurodegeneration studies.

medRxiv : the preprint server for health sciences·2026
Same author

Comparative analysis of robot-assisted minimally invasive esophagectomy versus conventional minimally invasive esophagectomy, a systematic review and meta-analysis.

Journal of robotic surgery·2025
Same author

Retraction notice to "Evaluating the influence of characteristics on the acceptance of artificial intelligence application: An empirical study" [Heliyon 10 (2024) e39460].

Heliyon·2025

Related Experiment Video

Updated: Jun 7, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.5K

Electroconvulsive Therapy in a Left Ventricular Assist Device Recipient With Treatment-Resistant Depression.

Rebekah Nash1, Daniel Rosenkrans2, Lavinia Kolarczyk2

  • 1From the Department of Psychiatry, University of North Carolina School of Medicine.

The Journal of ECT
|November 12, 2024
PubMed
Summary

Left ventricular assist device (LVAD) recipients with depression can be safely treated with electroconvulsive therapy (ECT). This approach minimizes cardiovascular risks through multidisciplinary collaboration, offering hope for treatment-resistant cases.

Keywords:
electroconvulsive therapyinterventional psychiatryleft ventricular assist devicetreatment-resistant depression

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.0K
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

22.2K

Related Experiment Videos

Last Updated: Jun 7, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.5K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.0K
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
09:30

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

22.2K

Area of Science:

  • Cardiology
  • Psychiatry
  • Medical Devices

Background:

  • Depression and heart failure frequently coexist, affecting up to 35% of heart failure patients.
  • Left ventricular assist devices (LVADs) improve cardiac function but do not eliminate depression risk, with up to 24% of recipients experiencing it.
  • Managing depression in LVAD recipients is challenging due to risks of side effects, drug interactions, and contraindications for standard therapies.

Observation:

  • Electroconvulsive therapy (ECT) is effective for treatment-resistant depression.
  • ECT poses cardiovascular risks (bradycardia/hypotension, tachycardia/hypotension) for LVAD patients.
  • Close monitoring of cardiovascular status and LVAD function is crucial during ECT.

Findings:

  • This case report details the successful application of ECT in an LVAD recipient with treatment-resistant depression.
  • The study highlights a collaborative, multidisciplinary team approach to safely administer ECT.
  • Continuous monitoring allowed for minimization of associated cardiovascular risks.

Implications:

  • This case demonstrates a viable and safe method for delivering ECT to LVAD recipients.
  • The findings suggest that ECT can be a valuable treatment option for this complex patient population.
  • Further research into collaborative models for managing comorbid depression in LVAD patients is warranted.